Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATryn for DVT Prophylaxis in Hereditary Antithrombin Deficiency
NCT00056550Phase 3Completed
- Sponsor
- rEVO Biologics
- Start
- Dec 2002
- Primary completion
- Feb 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of antithrombin III in hereditary antithrombin deficiency, sponsored by rEVO Biologics. Started Dec 2002; status: completed.
02
Drugs
antithrombin III
03
Conditions
hereditary antithrombin deficiency
Beyond the preview
Go deeper on NCT00056550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056550.